Streptococcus mutans wall-associated protein A promotes TLR4-induced dendritic cell maturation

Area of Science:

• Immunology
• Microbial Pathogenesis
• Vaccinology

Background:

• Dendritic cells (DCs) are crucial for initiating immune responses, particularly in vaccination.
• Streptococcus mutans Wall-associated protein A (WapA) has shown potential in animal models for dental caries prevention.
• The immunomodulatory effects of WapA on DCs and innate immunity are not well understood.

Purpose of the Study:

• To investigate whether WapA activates innate immune responses.
• To determine the effects of WapA on dendritic cell (DC) maturation and function.
• To explore WapA's potential as an immune adjuvant.

Main Methods:

• WapA was cloned into a mammalian expression vector (pEBG) for fusion protein production (WapA-GST).
• Purified WapA-GST protein was used to pretreat DCs before stimulation with lipopolysaccharide (LPS).
• Activation of NF-κB and MAPK signaling pathways, cytokine production (IL-12, IL-6, TNF-α), and expression of DC maturation markers (CD80/86, CD40, MHC II) were analyzed.

Main Results:

• WapA-GST pretreatment potentiated LPS-induced activation of TLR4-mediated NF-κB and MAPK signaling pathways.
• WapA-GST significantly increased the production of pro-inflammatory cytokines (IL-12, IL-6, TNF-α) by DCs upon LPS stimulation.
• WapA pretreatment upregulated the expression of key DC maturation markers, including CD80/86, CD40, and MHC class II.

Conclusions:

• WapA is recognized by dendritic cells and acts as a potent stimulator of DC maturation.
• WapA enhances innate immune responses by boosting TLR4 signaling and pro-inflammatory cytokine release.
• These findings suggest WapA's potential utility in vaccine development as an adjuvant to improve immune responses.